From: Disease-specific differences in the use of traditional Korean medicine in Korea
Disease Name (ICD codec)) | Western medicine use | Traditional Korean medicine use | Dental and other medical service use | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Number | Proportion of number (S.E.) | Costb) | Proportion of cost | Number | Proportion of number (S.E.) | Costb) | Proportion of cost | Number | Proportion of number (S.E.) | Costb) | Proportion of cost | Number | Costb) |
Migraines and other headache syndromes (G43–G44) | 939 | 80.3% (1.16) | 18.8 | 79.8% | 229 | 19.6% (1.16) | 4.8 | 20.2% | 1 | 0.1% (0.09) | 0.01 | 0.0% | 1,169 | 23.6 |
Nerve, nerve root and plexus disorders (G50–G59) | 181 | 30.3% (1.88) | 2.5 | 29.7% | 410 | 68.7% (1.90) | 5.9 | 70.1% | 6 | 1.0% (0.41) | 0.02 | 0.2% | 597 | 8.5 |
Intracranial hemorrhage (I60–I62) | 543 | 38.9% (1.30) | 5.9 | 57.0% | 828 | 59.3% (1.31) | 4.0 | 38.6% | 26 | 1.9% (0.36) | 0.45 | 4.4% | 1,397 | 10.3 |
Cerebral infarction (I63) | 682 | 82.0% (1.30) | 8.6 | 72.3% | 147 | 17.7% (1.32) | 3.3 | 27.6% | 3 | 0.4% (0.21) | 0.01 | 0.1% | 832 | 11.8 |
Other diseases of the circulatory system (I85–I99) | 596 | 50.3% (1.45) | 5.0 | 36.0% | 581 | 49.0% (1.45) | 8.9 | 64.0% | 8 | 0.7% (0.24) | 0.01 | 0.1% | 1,185 | 13.9 |
Other acute upper respiratory infections (J00–J01, J05–J06) | 48,393 | 99.3% (0.04) | 150.8 | 94.9% | 300 | 0.6% (0.04) | 7.3 | 4.6% | 39 | 0.1% (0.01) | 0.75 | 0.5% | 48,732 | 158.8 |
Other diseases of the nose and nasal sinuses (J30–J31, J33–J34) | 4,335 | 94.1% (0.35) | 20.1 | 66.2% | 267 | 5.8% (0.34) | 10.2 | 33.5% | 5 | 0.1% (0.05) | 0.07 | 0.2% | 4,607 | 30.3 |
Gastritis and duodenitis (K29) | 3,603 | 96.5% (0.30) | 31.3 | 92.0% | 118 | 3.2% (0.29) | 2.7 | 7.9% | 11 | 0.3% (0.09) | 0.04 | 0.1% | 3,732 | 34.0 |
Other diseases of the esophagus, stomach and duodenum (K20–K23, K28, K30–K31) | 1,813 | 91.7% (0.62) | 19.4 | 75.9% | 158 | 8.0% (0.61) | 5.6 | 22.0% | 6 | 0.3% (0.12) | 0.55 | 2.1% | 1,977 | 25.6 |
Other diseases of the skin and subcutaneous tissues (L10–L99) | 7,207 | 95.9% (0.23) | 68.5 | 82.1% | 302 | 4.0% (0.23) | 14.9 | 17.9% | 6 | 0.1% (0.03) | 0.03 | 0.0% | 7,515 | 83.4 |
Rheumatoid arthritis and other inflammatory polyarthropathies (M05–M14) | 1,317 | 88.2% (0.83) | 9.2 | 84.1% | 175 | 11.7% (0.83) | 1.7 | 15.9% | 1 | 0.1% (0.07) | 0.01 | 0.1% | 1,493 | 10.9 |
Arthrosis (M15–M19) | 11,227 | 84.0% (0.32) | 59.6 | 77.8% | 2,062 | 15.4% (0.31) | 16.8 | 21.9% | 76 | 0.6% (0.07) | 0.23 | 0.3% | 13,365 | 76.6 |
Other disorders of the joints (M00–M03, M22–M25) | 830 | 74.2% (1.31) | 7.5 | 70.9% | 288 | 25.7% (1.31) | 3.1 | 29.0% | 1 | 0.1% (0.09) | 0.00 | 0.0% | 1,119 | 10.5 |
Cervical and other intervertebral disc disorders (M50–M51) | 4,359 | 77.5% (0.56) | 60.7 | 68.1% | 1,254 | 22.3% (0.56) | 28.4 | 31.8% | 8 | 0.1% (0.05) | 0.15 | 0.2% | 5,621 | 89.3 |
Other dorsopathies (M40–M49, M53–M54) | 9,514 | 74.2% (0.39) | 64.3 | 66.4% | 3,183 | 24.8% (0.38) | 32.1 | 33.2% | 127 | 1.0% (0.09) | 0.36 | 0.4% | 12,824 | 96.8 |
Soft tissue disorders (M60–M79) | 7,664 | 66.7% (0.44) | 52.1 | 61.6% | 3,798 | 33.1% (0.44) | 32.4 | 38.3% | 23 | 0.2% (0.04) | 0.12 | 0.1% | 11,485 | 84.7 |
Dislocations, sprains and strains of specified and multiple body regions (S03, S13, S23, S33, S43, S53, S63, S73, S83, S93, T03) | 3,328 | 72.3% (0.66) | 29.4 | 73.1% | 1,271 | 27.6% (0.66) | 10.4 | 25.8% | 6 | 0.1% (0.05) | 0.46 | 1.2% | 4,605 | 40.2 |
Other injuries of specified, unspecified and multiple body regions (S00–S01, S04, S09–S11, S14–S16, S19–S21, S24–S25, S29–S31, S34–S35, S39–S41, S44–S46, S49–S51, S54–S56, S59–S61, S64–S66, S69–S71, S74–S76,S79–S81, S84–S86, S89–S91, S94–S96,S99, T00–T01, T06–T07, T09, T11, T13–T14) | 2,526 | 90.1% (0.56) | 23.4 | 67.8% | 135 | 4.8% (0.40) | 1.3 | 3.9% | 143 | 5.1% (0.42) | 9.77 | 28.3% | 2,804 | 34.5 |
Sequelae of injuries, poisoning and other consequences of external causes (T90–T98) | 1,810 | 85.1% (0.77) | 13.1 | 89.1% | 310 | 14.6% (0.76) | 1.4 | 9.7% | 8 | 0.4% (0.13) | 0.16 | 1.1% | 2,128 | 14.7 |
the use for the invigorant | 7 | 1.3% (0.47) | 0.1 | 0.1% | 547 | 98.6% (0.51) | 96.7 | 99.7% | 1 | 0.2% (0.18) | 0.18 | 0.2% | 555 | 97.0 |